In collaboration with Benaroya Research Institute (BRI), Virginia Mason Franciscan Health is committed to providing exceptional and groundbreaking health care via clinical research.
As an internationally recognized leader in research for more than 60 years, BRI offers clinical trials for patients and families affected by Type 1 diabetes and other autoimmune diseases. The program’s goal is to help families with type 1 diabetes by investigating ways to prevent diabetes, finding new approaches of diagnosing the disease in its earliest stage to optimize the potential for successful treatment, and testing innovative new therapies. Learn more about diabetes research at Benaroya Research Institute.
The goal of our clinical research program is to provide each of our patients with a research option at every step of their disease, from screening for risk to initial diagnosis to long-term follow-up. Learn more about our diabetes clinical research studies.
Contact your doctor to learn more about opportunities for research and clinical trials through Benaroya Research Institute and Virginia Mason Franciscan Health.